US FDA Sees Leqembi Data As Vindicating Its Approach To Alzheimer’s Drugs

 
• By Brenda Sandburg
  
Alzheimer's puzzle
FDA touts confidence in connection between amyloid placque reduction and reduction in clinical decline • Source: Shutterstock
Pink Sheet Podcast

Have you checked out Pink Sheet podcast?

New episodes every Thursday.

SpotifyApple PodcastsWebsite

More from US FDA Performance Tracker

More from Regulatory Trackers